Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.6.6, indicating a backend/template update. This change reflects a version bump rather than modifications to study details or data.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedRevision label updated to v3.6.5 on the page. This indicates a minor maintenance update to the study page's content or metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record revision identifier was updated from v3.6.3 to v3.6.4, indicating a small backend/content management update.SummaryDifference0.1%

- Check57 days agoChange DetectedNew update dates 2026-07-15, 2026-07-13, and 2026-07 were added. Older update dates 2025-07-02, 2025-07-01, and 2025-07 were removed.SummaryDifference0.2%

- Check72 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, reflecting a minor version bump. This does not modify study information, eligibility criteria, or any user-facing content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a patch-level update to the published page. This change does not modify study details or user-facing functionality.SummaryDifference0.1%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.